Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial.
Pascal RichetteAugustin LatourteJérémie SellamDaniel WendlingMuriel PipernoPhilippe GoupilleYves-Marie PersFlorent EymardSébastien OttavianiPaul OrnettiRené-Marc FlipoBruno FautrelOlivier PeyrJean Pierre BertolaEric VicautXavier ChevalierPublished in: Annals of the rheumatic diseases (2020)
Tocilizumab was no more effective than placebo for pain relief in patients with hand osteoarthritis.
Keyphrases
- double blind
- placebo controlled
- rheumatoid arthritis
- phase iii
- phase ii
- study protocol
- clinical trial
- disease activity
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- chronic pain
- knee osteoarthritis
- phase ii study
- randomized controlled trial
- pain management
- neuropathic pain
- systemic lupus erythematosus
- spinal cord injury